nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.106	0.106	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0948	0.0948	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0908	0.0908	CbGpPWpGaD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0821	0.0821	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0772	0.0772	CbGpPWpGaD
Alitretinoin—RXRA—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0754	0.0754	CbGpPWpGaD
Alitretinoin—CRABP2—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.0412	0.0412	CbGpPWpGaD
Alitretinoin—CRABP1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.0412	0.0412	CbGpPWpGaD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—MST1—sclerosing cholangitis	0.0402	0.0402	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0253	0.0253	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0243	0.0243	CbGpPWpGaD
Alitretinoin—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0226	0.0226	CbGpPWpGaD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0189	0.0189	CbGpPWpGaD
Alitretinoin—RXRA—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0185	0.0185	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.0181	0.0181	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0164	0.0164	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0164	0.0164	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0151	0.0151	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0127	0.0127	CbGpPWpGaD
Alitretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.0125	0.0125	CbGpPWpGaD
Alitretinoin—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00987	0.00987	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—HIF1A—sclerosing cholangitis	0.00943	0.00943	CbGpPWpGaD
Alitretinoin—RXRA—Circadian Clock—HIF1A—sclerosing cholangitis	0.00919	0.00919	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—HIF1A—sclerosing cholangitis	0.00886	0.00886	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ABCB4—sclerosing cholangitis	0.00731	0.00731	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ABCB4—sclerosing cholangitis	0.00731	0.00731	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00673	0.00673	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00673	0.00673	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—GGT1—sclerosing cholangitis	0.00605	0.00605	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00591	0.00591	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—GGT1—sclerosing cholangitis	0.00531	0.00531	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00506	0.00506	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00497	0.00497	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—HIF1A—sclerosing cholangitis	0.00462	0.00462	CbGpPWpGaD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00455	0.00455	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TCF4—sclerosing cholangitis	0.00359	0.00359	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GOT2—sclerosing cholangitis	0.00347	0.00347	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GOT2—sclerosing cholangitis	0.00347	0.00347	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00318	0.00318	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GGT1—sclerosing cholangitis	0.003	0.003	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GOT1—sclerosing cholangitis	0.003	0.003	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—GOT1—sclerosing cholangitis	0.003	0.003	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—GGT1—sclerosing cholangitis	0.003	0.003	CbGpPWpGaD
Alitretinoin—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.00289	0.00289	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00289	0.00289	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00236	0.00236	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB4—sclerosing cholangitis	0.00221	0.00221	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00204	0.00204	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.00169	0.00169	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00159	0.00159	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT2—sclerosing cholangitis	0.00105	0.00105	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT1—sclerosing cholangitis	0.000908	0.000908	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GGT1—sclerosing cholangitis	0.000908	0.000908	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000885	0.000885	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000706	0.000706	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00065	0.00065	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.00042	0.00042	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000363	0.000363	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000363	0.000363	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	0.000335	0.000335	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	0.00029	0.00029	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	0.00029	0.00029	CbGpPWpGaD
